Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $9.42 USD
Change Today -0.16 / -1.67%
Volume 72.7K
RXDX On Other Exchanges
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

ignyta inc (RXDX) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/8/15 - $11.07
52 Week Low
11/20/14 - $6.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IGNYTA INC (RXDX)

Related News

No related news articles were found.

ignyta inc (RXDX) Related Businessweek News

No Related Businessweek News Found

ignyta inc (RXDX) Details

Ignyta, Inc., a precision oncology biotechnology company, engages in discovering or acquiring, developing, and commercializing new drugs for cancer patients. Its products pipeline consists of entrectinib, a tyrosine kinase inhibitor directed to the Trk family tyrosine kinase receptors, ROS1, and ALK proteins, which is in two Phase I/II clinical studies in molecularly defined patient populations for the treatment of solid tumors; and RXDX-103, a development program targeting the cell division cycle 7-related and protein kinase. The company was founded in 2011 and is based in San Diego, California.

57 Employees
Last Reported Date: 03/12/15
Founded in 2011

ignyta inc (RXDX) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $608.3K
Chief Operating Officer
Total Annual Compensation: $455.1K
Clinical and Regulatory Strategy Officer
Total Annual Compensation: $163.7K
Compensation as of Fiscal Year 2014.

ignyta inc (RXDX) Key Developments

Ignyta, Inc. Announces Audited Earnings Results for the Year Ended December 31, 2014

Ignyta, Inc. announced audited earnings results for the year ended December 31, 2014. For the year, the company reported revenue of $150,000. Loss from operations of $39,849,000 compared to $13,902,000 a year ago. Loss before income tax was $39,978,000 compared to $14,212,000 a year ago. Net loss was $39,990,000 or $2.18 per basic and diluted share compared to $14,214,000 or $3.83 per basic and diluted share a year ago.

Ignyta, Inc. to Report Q4, 2014 Results on Mar 17, 2015

Ignyta, Inc. announced that they will report Q4, 2014 results After-Market on Mar 17, 2015

Ignyta, Inc., Q4 2014 Earnings Call, Mar 17, 2015

Ignyta, Inc., Q4 2014 Earnings Call, Mar 17, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXDX:US $9.42 USD -0.16

RXDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RXDX.
View Industry Companies

Industry Analysis


Industry Average

Valuation RXDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,251.5x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 914.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IGNYTA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at